ClinicalTrials.gg
CompletedNCT05703334Updated Sep 6, 2023

Kt and Myofascial Release in Exc Asthma

An interventional study of Kinesio tap in Exercise Induced Asthma, sponsored by Cairo University. Completed at 1 site in Egypt. Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-06.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Male
01

Study summary

Purpose of this study was to compare between the effects of kinesio tap and myofascial release of respiratory muscles on exercise induced asthma

Read the detailed description

seventy male athletic subjects with exercise induced asthma, their age ranged from 18-30 years old in this study , with group (A) mean age (21.03+3.6 years), and mean BMI values (27.6+.9 kg/m2) ,and group (B) mean age (21.9+3.8 years),and mean BMI values (27.8+1.3 kg/m2), and group (C) mean age(22+3.1 years), and mean BMI values (27.8+1.3 kg/m2).

Subjects were assigned randomly into tow study groups and one control group:Group(A) 30 subjects were treated by kinesio tap therapy 2sessions per week,Ground(B) 30 subjects were treated by myofascial release therapy 3 sessions per week ,Group (C) 10 subjects were not recieved treatment.

02

Conditions studied

  • Exercise Induced Asthma

Keywords

  • Pulmonary function test
03

In context

Asthma, Exercise-Induced

52 studies on the registry are indexed under Asthma, Exercise-Induced; 3 are open to participants now.

This study's enrollment of 70 is above the median of 47 across 40 interventional studies indexed under Asthma, Exercise-Induced.

Browse Asthma, Exercise-Induced studies →

Lead sponsor

Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Seventy male athlete with ages ranging from 18 to 28 years old. Their ranged from "18.5" to "24.9". They have the same level of good aerobic fitness, muscular strength and endurance, and flexibility according to tests results; running or jogging test, push up or sit up test, and sit-and-reach test respectively.

Exclusion criteria

Exclusion Criteria:

  1. Pulmonary disorders.
  2. Metabolic disorders (e.g. Diabetes Mellitus).
  3. Coronary artery disorders .
  4. Neurological disorders.
  5. Recent musculoskeletal injuries.
  6. Renal disorders.
  7. Hepatic disorders.
  8. Skin hypersensitive.
  9. Smokers
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Kinesio tap

    group (A) mean age (21.03+3.6 years), and mean BMI values (27.6+.9 kg/m2 Group(A) 30 subjects were treated by kinesio tap therapy 2sessions per week.

    Other: Kinesio tap

  • Experimental
    Myofascial release

    group (B) mean age (21.9+3.8 years),and mean BMI values (27.8+1.3 kg/m2 Ground(B) 30 subjects were treated by myofascial release therapy 3 sessions per week .

    Other: Kinesio tap

  • No intervention
    Control group

Interventions

  • OtherKinesio tap

    Applied on pulmonary muscles :diaphragm muscle and abdominal muscle and sternocleinomastoid muscle 3 time per weak for 2 mounth

    Also known as: Myofascial release

06

What researchers measure

Primary outcomes

  1. Pulmonary function test

    MVV :liter FVC:liter FEV1:liter FVC/FEV1:% VC:liter

    Time frame: 2 months

Secondary outcomes

  1. Cooper's 12 minute run test

    Vo2 max:ml/kg/min

    Time frame: 2 months

Other outcomes

  1. pulse oximeter

    Pao2:%

    Time frame: 2 months

  2. IFIS

    General fitness

    Time frame: 2 months

07

Study locations

1 site
  • Khaled mohamed Ahmed zaki
    Port Said, Port Said/el Manakh 42511, Egypt
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05703334
Lead sponsor
Cairo University
Responsible party
Khaled mohammed Ahmed zaki (Dr khaled zaki, Cairo University) — Principal investigator
First posted
Jan 30, 2023
Start date
Jan 20, 2023
Primary completion
Apr 20, 2023
Completion
May 20, 2023
Last update
Sep 6, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion